KöhneC.H., WilkeH., SchöffskiP., KäuferC., RaucheckerH., HiddemanW., HorstM., OhlU., HeckerH., SchmollH.-J.: High dose infusional 5-FU plus folinic acid is superior compared to HD-FU plus interferon. Final results of a multicenter randomized trial of the AIO.Ann. Oncol.,7(suppl. 5): 45, 1996.
2.
LeviF.A., ZidaniR., VannetzelJ.-M, PerpointB., FocanC., FaggiuloR., CholletP., GarufiC., ItzhakiM., DogliottiL., IacobelliS., AdamR., KunstlingerF., GastiaburnJ., BismuthH., JasminC., MissetJ.-L.: Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil and folinic acid in patients with colorectal cancer metastases: a randomized multi-institutional trial.J. Natl. Cancer Inst., 86: 1608–1617, 1994.
3.
LokichJ.J., AhlegrenJ.D., GulloJ.J., PhilipsJ.A., FryerJ.: A prospective randomized comparison of continuos infusion with a conventional bolus schedule in metastatic colorectal carcinoma.J. Clin. Oncol., 7: 425–432, 1989.
4.
O'ConnellM.J., MartensonJ.A., WieandH.S., KrookJ.E., MacDonaldJ.S., HallerD.G., MayerR.J., GundersonL.L., RichT.A.: Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery.N. Engl. J. Med., 331: 502–507, 1994.
